Stroke remains a major health care challenge worldwide and is the third leading cause of death and the leading cause of disability in developed countries. The management of acute ischemic stroke has advanced greatly over the past 20 years. Now the treatment of stroke can be describe with one word- variety.
The current review is dedicated to the problems of endovascular treatment in acute ischemic stroke. The different methods of treatment, pros and cons of each of them, discussing the different options for the patients are presented.
Balwinder S., P. Ajay, P. Larry, M. Manoj,Endovascular Therapy for Acute Ischemic Stroke: A Systematic Review and Meta-analysis. Mayo Clinic Proceedings, 2013;88(10):1056-1065.
Bambauer K.Z., S.C. Johnston, D.E. Bambauer, J.A. Zivin. Reasons why few patients with acute stroke receive tissue plasminogen activator. Arch Neurol, 63, 2006, No 5, 661–664;
Barber P.A., J. Zhang, A.M. Demchuk, M.D. Hill, A.M. Buchan. Why are stroke patients excluded from TPA therapy? An analysis of patient eligibility. Neurology, 56, 2001, No 8, 1015–1020;
Blackham K.A., P.M. Meyers, T.A. Abruzzo,F.C. Alberquerque, D. Fiorella, J. Fraser, D. Frei. Endovascular Therapy of Acute Ischemic Stroke. J NeuroIntervent Surg, 4, 2012; No 2, 87-93.
Broderick J.P. Endovascular therapy for acute ischemic stroke. Stroke, 40, 2009, No 7, 103–106.
Broderick J.P., Y.Y. Palesch , A.M. Demchuk. Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 368, 2013, No 10, 893–903;
Broussalis E, E. Trinka , W. Hitzl , A. Wallner , V. Chroust , M. Killer-Oberpfalzer . Comparison of stent-retriever devices versus the Merci retriever
for endovascular treatment of acute stroke. Am J Neuroradiol., 34, 2013, No 2, 366–372;
Ciccone A, L. Valvassori , M. Nichelatti , A. Sgoifo, M. Ponzio , R. Sterzi ; Endovascular treatment for acute ischemic stroke. N Engl J Med., 368, 2013, No 10, 904-913.
Chimowitz M.I. Endovascular treatment for acute ischemic stroke–still unproven. N Engl J Med., 368, 2013, No 10, 952–955;
Hacke W, H. Zeumer, A. Ferbert, H. Brückmann, G.J. del Zoppo. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke, 19, 1988, No 10, 1216–1222;
Hacke W., M. Kaste, E. Bluhmki. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med, 359, 2008, No 13, 1317-1329;
Mori E, M. Tabuchi, T. Yoshida, A. Yamadori. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke, 19, 1988, No 7, 802-812;
Nam J., H. Jing, D. O'Reilly. Intra-arterial thrombolysis vs. standard treatment or intravenous thrombolysis in adults with acute ischemic stroke: a systematic review and metaanalysis. Int J Stroke, 12, 2013, No 7, 227-312.
Nogueira R.G., L.H. Schwamm, J.A. Hirsch. Endovascular approaches to acute stroke, part 1: drugs, devices, and data. AJNR Am J Neuroradiol, 30, 2009, No 4, 649-661;
Rha J.H., J.L. Saver . The impact of recanalization on ischemic stroke outcome: a meta-analysis. Stroke, 38, 2007, No 3, 967-973;
Theron J., P. Courtheoux, A. Casasco. Local intraarterial fibrinolysis in the carotid territory. AJNR Am J Neuroradiol, 10, 1989, No 4, 753-765;;
Qureshi A.I., A.M. Siddiqui, M.F. Suri. Aggressive mechanical clot disruption and low-dose intra-arterial thirdgeneration thrombolytic agent for ischemic stroke: a prospective study. Neurosurgery, 51, 2002, No 5, 1319-1327;
Zeumer H., H.J. Freitag, U. H.P. Grzyska, Neunzig. Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results. Neuroradiology, 31, 1989, No 4, 336-340.